← Home
This Week in Startups · April 28, 2026 · 00:53:03

China Kills Meta / Manus Deal (Story Of The Year) | E2281

Lon Harris
Spotify

Jason Calacanis and Lon Harris discuss what they consider the technology story of 2026: China's government blocking Meta's acquisition of Manus, a major AI company founded in China that had attempted to sidestep government control by relocating to Singapore. The episode also covers the reworked OpenAI-Microsoft partnership, a disturbing video of a self-driving car accident in China, and closes with discussion of cultural moments including Russell Brand's recent controversies.

This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.

Highlights

•
China's Manus Block Closes the Singapore AI Loophole
China's government decision to block Meta's acquisition of Manus reveals that the strategy of Chinese AI founders relocating to Singapore to escape government oversight no longer works.
ClaudeChatGPTGemini
•
OpenAI-Microsoft Partnership Requires Structural Rework
OpenAI and Microsoft have reworked their operating agreement, indicating that despite a mutually beneficial relationship, structural tensions required resolution.
ClaudeChatGPTGemini

Editorial

•
Technology's Defining Story of 2026 Is Geopolitical, Not Technical
Jason argues the year's most significant tech story isn't about AI model breakthroughs or IPOs, but about China's geopolitical assertion of control over AI development.
ClaudeChatGPTGemini
•
Autonomous Vehicle Liability Differs Radically Across Jurisdictions
A video from China showing a self-driving car hitting a child at speed raises questions about how different legal systems would handle such an incident.
ClaudeChatGPTGemini

Misc

✧Jason argues China blocking the Manus deal represents a fundamental shift in AI geopolitics — not a loophole but a closing door
✧The Singapore relocation strategy for Chinese AI founders is now considered a failed approach
✧Discussion of autonomous vehicle liability and regulatory response differs dramatically between US and China
Was this useful?